Small molecules supporting pluripotent cell growth and methods thereof
The present invention relates to compositions and methods for maintaining undifferentiated pluripotent stem cell cultures.
1. A composition comprising:
(a) a defined cell culture medium that is sufficient to achieve undifferentiated expansion of human pluripotent cells cultured therein;
(b) one or more human pluripotent cells present at low cell density in the defined cell culture medium; and
(c) norepinephrine or a structural analog, derivative, or physiologically acceptable salt thereof present in the defined culture medium in an amount that is sufficient to achieve low density survival and expansion of pluripotent cells.
2. The composition of claim 1 , comprising at least one growth factor.
3. The composition of claim 2 , wherein the at least one the growth factor is selected from the group consisting of: an ErbB3 ligand or a functional fragment thereof a TGF-β family member or a functional fragment thereof an activator of insulin-like growth factor receptor (IGF-1R) or a functional fragment thereof and an activator of a fibroblast growth factor (FGF) receptor or a functional fragment thereof.
4. The composition of claim 3 , wherein the ErbB3 ligand is selected from the group consisting of Neuregulin-1, Heregulin-β (HRG-β), Heregulin-α(HRG-α), Neu differentiation factor (NDF), acetylcholine receptor-inducing activity (ARIA), glial growth factor 2 (GGF2), sensory and motor neuron-derived factor (SMDF), Neuregulin-2; Epiregulin, Biregulin, and functional fragments thereof.
5. The composition of claim 1 , wherein the one or more human pluripotent cells are dissociated to single cells and aggregated in suspension.
6. The composition of claim 1 , wherein the one or more human pluripotent cells are in a substantially euploid state.
7. A method for expanding a human pluripotent cell, the method comprising the step of incubating one or more human pluripotent cells present at low cell density in a composition comprising:
(a) a defined cell culture medium that is sufficient to achieve undifferentiated expansion of human pluripotent cells cultured therein; and
(b) norepinephrine or a structural analog, derivative, or physiologically acceptable salt thereof present in the defined culture medium in an amount that is sufficient to achieve low density survival and expansion of pluripotent cells.